Dr. Karen W. Oxford, MD

Dr. Oxford practices at Pacific Eye Associates, a Medical Corporation in San Francisco, California.

Dr. Oxford's NPI, 1396746749, was assigned on August 9, 2005. Dr. Oxford graduated from Keck School of Medicine of USC in 1990. Dr. Oxford holds California license G78840.

Dr. Oxford's primary practice is Pacific Eye Associates, a Medical Corporation, at 2100 Webster St, San Francisco, CA 94115 in San Francisco County. The practice phone is (415) 923-3007.

Dr. Oxford's primary practice is Pacific Eye Associates, a Medical Corporation in San Francisco, California. Dmand AI also links Dr. Oxford to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oxford practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Oxford's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Oxford is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Oxford is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Oxford treats.

CMS data shows 2,425 Medicare services from Dr. Oxford across 14 procedure codes in 2024, for 1,168 Medicare patients. Medicare paid $201,420 for them.

CMS counts 1,168 Medicare patients who saw Dr. Oxford in 2024. The largest group is 75 to 84, with 500 patients. 72% of them have high cholesterol, and 63% have high blood pressure. 20% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Oxford's median patient age at 76, with 53% women.

In 2024, Dr. Oxford wrote 1,208 Medicare Part D claims for 281 patients. 54% of them were for generic drugs. CMS names the drug for 1,094 of them, across 21 drugs with 11 or more claims each, at $234,024 in total drug cost. In 2023, CMS named 1,047 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Oxford for performance year 2024, reported as part of a group.

Dmand AI links 4 papers to Dr. Oxford. The most frequent topics are Corneal Injuries. Dr. Oxford has published most often in Am J Ophthalmol. Dr. Oxford's most frequent co-authors are Richard L. Abbott, MD and Anne E. Fung, MD.

CMS Open Payments shows 375 general payments to Dr. Oxford from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Shire North American Group Inc paid the most, $68,463.

Dr. Oxford graduated from Keck School of Medicine of USC in 1990.

Dr. Oxford is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.